{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:50:59Z","timestamp":1793875859543,"version":"4.7.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03ZU1109CB"],"award-info":[{"award-number":["03ZU1109CB"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03ZU1109CC"],"award-info":[{"award-number":["03ZU1109CC"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-catalytic heterobifunctional protein binders promise to expand the range of therapeutic options by establishing complexes between key target proteins and accessory presenter proteins equipped with additional properties. Here, we systematically investigate the rational design of such molecules, explore the biochemical basis of complex formation and determine how they achieve cellular efficacy using the endogenously expressed immunophilin FKBP12 as presenter protein and the transcriptional regulator BRD4 as target protein. We present classes of bifunctional molecules that enable selective, FKBP12-dependent killing of specific cell types at subnanomolar concentrations and allow to differentiate between closely related bromodomains of the BET family. We propose that the strongly potentiated efficacy of these bifunctional compounds is based on cellular enrichment through binding to the highly abundant presenter protein FKBP12, a mechanism we term \u201cCellTrap\u201d. Our findings substantiate the concept that highly expressed, non-essential proteins can be repurposed as selective recruiters to expand therapeutic windows of existing small-molecule inhibitors, opening new avenues for designing targeted drugs with improved cell-type specificity.<\/jats:p>","DOI":"10.1038\/s41467-026-77460-w","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:23:51Z","timestamp":1789669431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cell type\u2013selective targeting by heterobifunctional protein binders via in-cell enrichment"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9826-6060","authenticated-orcid":false,"given":"Ahmed","family":"Bulldan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Meyners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick L.","family":"Purder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes K.","family":"Dreizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max L.","family":"Repity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0655-1940","authenticated-orcid":false,"given":"Marte H\u00f8en","family":"Lein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3009-1064","authenticated-orcid":false,"given":"Ingrid","family":"Quist-L\u00f8kken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9421-5638","authenticated-orcid":false,"given":"Noel","family":"Tewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6916-2900","authenticated-orcid":false,"given":"Katjana","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3429-1876","authenticated-orcid":false,"given":"Martin","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-1829","authenticated-orcid":false,"given":"Martin P.","family":"Schwalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghunath","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-4084","authenticated-orcid":false,"given":"Saran","family":"Aswathaman Sivashanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7880-3936","authenticated-orcid":false,"given":"Sarah","family":"Schlesiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-8075","authenticated-orcid":false,"given":"Sebastien","family":"Moniot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-6494","authenticated-orcid":false,"given":"Stefan","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-679X","authenticated-orcid":false,"given":"Ingo V.","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2051-5824","authenticated-orcid":false,"given":"Toril","family":"Holien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8819-3040","authenticated-orcid":false,"given":"Alexander","family":"Loewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3710-8838","authenticated-orcid":false,"given":"Felix","family":"Hausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"77460_CR1","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.2174\/092986711798194342","volume":"18","author":"S Gaali","year":"2011","unstructured":"Gaali, S., Gopalakrishnan, R., Wang, Y., Kozany, C. & Hausch, F. The chemical biology of immunophilin ligands. Curr. Med. Chem. 18, 5355\u20135379 https:\/\/doi.org\/10.2174\/092986711798194342 (2011).","journal-title":"Curr. Med. Chem."},{"key":"77460_CR2","doi-asserted-by":"crossref","unstructured":"B\u00e9k\u00e9s, M.; Langley, D. R.; Crews, C. M. PROTAC Targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","DOI":"10.1038\/s41573-021-00371-6"},{"key":"77460_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-023-06348-2","volume":"620","author":"S Gourisankar","year":"2023","unstructured":"Gourisankar, S. et al. Rewiring cancer drivers to activate apoptosis. Nature 620, 417\u2013425 https:\/\/doi.org\/10.1038\/s41586-023-06348-2 (2023).","journal-title":"Nature"},{"key":"77460_CR4","doi-asserted-by":"crossref","unstructured":"Modell, A. E., Lai, S., Nguyen, T. M. & Choudhary, A. Bifunctional Modalities for Repurposing Protein Function. Cell Chem. Biol. 28, 1081\u20131089 (2021).","DOI":"10.1016\/j.chembiol.2021.06.005"},{"key":"77460_CR5","doi-asserted-by":"crossref","unstructured":"Nalawansha, D. A., Mangano, K., den Besten, W. & Potts, P. R. TAC-Tics for leveraging proximity biology in drug discovery. ChemBioChem. 25, e202300712 (2024).","DOI":"10.1002\/cbic.202300712"},{"key":"77460_CR6","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.chembiol.2024.07.005","volume":"31","author":"K Raina","year":"2024","unstructured":"Raina, K. et al. Regulated induced proximity targeting chimeras\u2014RIPTACs\u2014A heterobifunctional small molecule strategy for cancer selective therapies. Cell Chem. Biol. 31, 1490\u20131502 https:\/\/doi.org\/10.1016\/j.chembiol.2024.07.005 (2024).","journal-title":"Cell Chem. Biol."},{"key":"77460_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/d41573-025-00037-7","volume":"24","author":"A Mullard","year":"2025","unstructured":"Mullard, A. Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic. Nat. Rev. Drug Discov. 24, 235\u2013237 https:\/\/doi.org\/10.1038\/d41573-025-00037-7 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77460_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41586-024-07950-8","volume":"633","author":"CSC Ng","year":"2024","unstructured":"Ng, C. S. C., Liu, A., Cui, B. & Banik, S. M. Targeted protein relocalization via protein transport coupling. Nature 633, 941\u2013951 https:\/\/doi.org\/10.1038\/s41586-024-07950-8 (2024).","journal-title":"Nature"},{"key":"77460_CR9","doi-asserted-by":"publisher","first-page":"24788","DOI":"10.1021\/jacs.3c12389","volume":"146","author":"Q Shao","year":"2024","unstructured":"Shao, Q., Duong, T. N., Park, I., Orr, L. M. & Nomura, D. K. Targeted protein localization by covalent 14\u20133\u20133 recruitment. J. Am. Chem. Soc. 146, 24788\u201324799 https:\/\/doi.org\/10.1021\/jacs.3c12389 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"77460_CR10","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1021\/ja021327y","volume":"125","author":"R Sedrani","year":"2003","unstructured":"Sedrani, R. et al. Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, x-ray crystal structure, and binding data. J. Am. Chem. Soc. 125, 3849\u20133859 https:\/\/doi.org\/10.1021\/ja021327y (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"77460_CR11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1126\/science.adg9652","volume":"381","author":"CJ Schulze","year":"2023","unstructured":"Schulze, C. J. et al. Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS. Science 381, 794\u2013799 https:\/\/doi.org\/10.1126\/science.adg9652 (2023).","journal-title":"Science"},{"key":"77460_CR12","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1021\/acs.jmedchem.4c02313","volume":"68","author":"J Cregg","year":"2025","unstructured":"Cregg, J. et al. Discovery of elironrasib (RMC-6291), a potent and orally bioavailable, RAS(ON) G12C-selective, covalent tricomplex inhibitor for the treatment of patients with RAS G12C-addicted cancers. J. Med. Chem. 68, 6041\u20136063 https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02313 (2025).","journal-title":"J. Med. Chem."},{"key":"77460_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/dmd.122.001154","volume":"51","author":"LP Volak","year":"2023","unstructured":"Volak, L. P. et al. Industry perspective on the pharmacokinetic and absorption, distribution, metabolism, and excretion characterization of heterobifunctional protein degraders. S. Drug Metab. Dispos. 51, 792\u2013803 https:\/\/doi.org\/10.1124\/dmd.122.001154 (2023).","journal-title":"S. Drug Metab. Dispos."},{"key":"77460_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"J Liu","year":"1991","unstructured":"Liu, J. et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807\u2013815 https:\/\/doi.org\/10.1016\/0092-8674(91)90124-H (1991).","journal-title":"Cell"},{"key":"77460_CR15","doi-asserted-by":"publisher","unstructured":"Kolos, J. M., Voll, A. M., Bauder, M. & Hausch, F. FKBP Ligands\u2014where we are and where to go? Front. Pharmacol.https:\/\/doi.org\/10.3389\/fphar.2018.01425 (2018).","DOI":"10.3389\/fphar.2018.01425"},{"key":"77460_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","volume":"184","author":"SL Schreiber","year":"2021","unstructured":"Schreiber, S. L. The rise of molecular glues. Cell 184, 3\u20139 https:\/\/doi.org\/10.1016\/j.cell.2020.12.020 (2021).","journal-title":"Cell"},{"key":"77460_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102148","volume":"68","author":"MP Schwalm","year":"2022","unstructured":"Schwalm, M. P. & Knapp, S. BET Bromodomain inhibitors. Curr. Opin. Chem. Biol. 68, 102148 https:\/\/doi.org\/10.1016\/j.cbpa.2022.102148 (2022).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"77460_CR18","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 https:\/\/doi.org\/10.1038\/nature09504 (2010).","journal-title":"Nature"},{"key":"77460_CR19","doi-asserted-by":"publisher","first-page":"14758","DOI":"10.1039\/D1SC04638A","volume":"12","author":"JM Kolos","year":"2021","unstructured":"Kolos, J. M. et al. Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] Aza-Amides. Chem. Sci. 12, 14758\u201314765 https:\/\/doi.org\/10.1039\/D1SC04638A (2021).","journal-title":"Chem. Sci."},{"key":"77460_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/anie.201408776","volume":"54","author":"S Pomplun","year":"2015","unstructured":"Pomplun, S. et al. Rational design and asymmetric synthesis of potent and neurotrophic ligands for FK506-binding proteins (FKBPs). Angew. Chem. Int. Ed. 54, 345\u2013348 https:\/\/doi.org\/10.1002\/anie.201408776 (2015).","journal-title":"Angew. Chem. Int. Ed."},{"key":"77460_CR21","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1021\/jacsau.3c00241","volume":"3","author":"PL Purder","year":"2023","unstructured":"Purder, P. L. et al. Deconstructing protein binding of sulfonamides and sulfonamide analogues. JACS Au 3, 2478\u20132486 https:\/\/doi.org\/10.1021\/jacsau.3c00241 (2023).","journal-title":"JACS Au"},{"key":"77460_CR22","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1021\/acs.jmedchem.8b00137","volume":"61","author":"S Pomplun","year":"2018","unstructured":"Pomplun, S. et al. Chemogenomic profiling of human and microbial FK506-binding proteins. J. Med. Chem. 61, 3660\u20133673 https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00137 (2018).","journal-title":"J. Med. Chem."},{"key":"77460_CR23","doi-asserted-by":"publisher","unstructured":"Wang, Y. K. et al. Medicinal chemistry of anti-HIV-1 latency chemotherapeutics: biotargets, binding modes and structure-activity relationship investigation. Molecules. 28,https:\/\/doi.org\/10.3390\/molecules28010003 (2022).","DOI":"10.3390\/molecules28010003"},{"key":"77460_CR24","doi-asserted-by":"publisher","unstructured":"Geiger, T. M. et al. Discovery of a potent proteolysis targeting chimera enables targeting the scaffolding functions of FK506-binding protein 51 (FKBP51). Angew. Chem. Int. Ed. 63,https:\/\/doi.org\/10.1002\/anie.202309706 (2024).","DOI":"10.1002\/anie.202309706"},{"key":"77460_CR25","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/cbic.200800806","volume":"10","author":"C Kozany","year":"2009","unstructured":"Kozany, C., M\u00e4rz, A., Kress, C. & Hausch, F. Fluorescent probes to characterise FK506-binding proteins. ChemBioChem 10, 1402\u20131410 https:\/\/doi.org\/10.1002\/cbic.200800806 (2009).","journal-title":"ChemBioChem"},{"key":"77460_CR26","doi-asserted-by":"crossref","unstructured":"Gnatzy, M. T. et al. Development of NanoBRET-binding assays for FKBP-ligand profiling in living cells. ChemBioChem 22, 2257\u20132261 (2021).","DOI":"10.1002\/cbic.202100113"},{"key":"77460_CR27","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1158\/0008-5472.CAN-12-3292","volume":"73","author":"S Picaud","year":"2013","unstructured":"Picaud, S. et al. PFI-1, a Highly selective protein interaction inhibitor, targeting BET bromodomains. Cancer Res. 73, 3336\u20133346 https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3292 (2013).","journal-title":"Cancer Res."},{"key":"77460_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.06.019","author":"U Moran","year":"2010","unstructured":"Moran, U., Phillips, R. & Milo, R. SnapShot: Key numbers in biology. Cell https:\/\/doi.org\/10.1016\/j.cell.2010.06.019 (2010).","journal-title":"Cell"},{"key":"77460_CR29","doi-asserted-by":"publisher","unstructured":"Petzold, G. et al. Mining the CRBN target space redefines rules for molecular glue\u2013induced neosubstrate recognition. Science. 389,https:\/\/doi.org\/10.1126\/science.adt6736 (20225).","DOI":"10.1126\/science.adt6736"},{"key":"77460_CR30","doi-asserted-by":"crossref","unstructured":"Smith, B. E. et al. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat. Commun. 10, 131 (2019).","DOI":"10.1038\/s41467-018-08027-7"},{"key":"77460_CR31","doi-asserted-by":"crossref","unstructured":"Guenette, R. G., Yang, S. W., Min, J., Pei, B. & Potts, P. R. Target and tissue selectivity of PROTAC degraders. Chem. Soc. Rev. 51, 5740\u20135756 (2022).","DOI":"10.1039\/D2CS00200K"},{"key":"77460_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1039\/b720011k","volume":"4","author":"PS Marinec","year":"2008","unstructured":"Marinec, P. S., Lancia, J. K. & Gestwicki, J. E. Bifunctional molecules evade cytochrome P450 metabolism by forming protective complexes with FK506-binding protein. Mol. Biosyst. 4, 571\u2013573 https:\/\/doi.org\/10.1039\/b720011k (2008).","journal-title":"Mol. Biosyst."},{"key":"77460_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41586-024-07205-6","volume":"629","author":"M Holderfield","year":"2024","unstructured":"Holderfield, M. et al. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy. Nature 629, 919\u2013926 https:\/\/doi.org\/10.1038\/s41586-024-07205-6 (2024).","journal-title":"Nature"},{"key":"77460_CR34","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1073\/pnas.0805375106","volume":"106","author":"PS Marinec","year":"2009","unstructured":"Marinec, P. S. et al. FK506-Binding protein (FKBP) partitions a modified HIV protease pnhibitor into blood cells and prolongs its lifetime in vivo. Proc. Natl. Acad. Sci. USA 106, 1336\u20131341 https:\/\/doi.org\/10.1073\/pnas.0805375106 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77460_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0014-5793(95)00062-E","volume":"360","author":"ZX Wang","year":"1995","unstructured":"Wang, Z. X. An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule. FEBS Lett. 360, 111\u2013114 https:\/\/doi.org\/10.1016\/0014-5793(95)00062-E (1995).","journal-title":"FEBS Lett."},{"key":"77460_CR36","doi-asserted-by":"publisher","unstructured":"Gerlach, M., Mueller, U. & Weiss, M. S. The MX beamlines BL14.1-3 at BESSY II. J. Large Scale Res. Facil. 2,https:\/\/doi.org\/10.17815\/jlsrf-2-64 (2016).","DOI":"10.17815\/jlsrf-2-64"},{"key":"77460_CR37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1107\/S0909049510020005","volume":"17","author":"J Gabadinho","year":"2010","unstructured":"Gabadinho, J. et al. MxCuBE: A synchrotron beamline control environment customized for macromolecular crystallography experiments. J. Synchrotron Radiat. 17, 700\u2013707 https:\/\/doi.org\/10.1107\/S0909049510020005 (2010).","journal-title":"J. Synchrotron Radiat."},{"key":"77460_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80263-y","volume":"14","author":"AD Behsen","year":"2024","unstructured":"Behsen, A. D. et al. Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy. Sci. Rep. 14, 28805 https:\/\/doi.org\/10.1038\/s41598-024-80263-y (2024).","journal-title":"Sci. Rep."},{"key":"77460_CR39","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/s41596-024-00979-z","volume":"19","author":"MP Schwalm","year":"2024","unstructured":"Schwalm, M. P., Saxena, K., M\u00fcller, S. & Knapp, S. Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cells. Nat. Protoc. 19, 2317\u20132357 https:\/\/doi.org\/10.1038\/s41596-024-00979-z (2024).","journal-title":"Nat. Protoc."},{"key":"77460_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49896-5","volume":"15","author":"J Dopfer","year":"2024","unstructured":"Dopfer, J. et al. TracerDB: A crowdsourced fluorescent tracer database for target engagement analysis. Nat. Commun. 15, 5646 https:\/\/doi.org\/10.1038\/s41467-024-49896-5 (2024).","journal-title":"Nat. Commun."},{"key":"77460_CR41","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.3324\/haematol.2024.287047","volume":"110","author":"I Quist-L\u00f8kken","year":"2025","unstructured":"Quist-L\u00f8kken, I. et al. Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma. Haematologica 110, 2487\u20132492 https:\/\/doi.org\/10.3324\/haematol.2024.287047 (2025).","journal-title":"Haematologica"},{"key":"77460_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202200615","volume":"18","author":"J Krieger","year":"2023","unstructured":"Krieger, J. et al. Systematic potency and property assessment of VHL ligands and implications on PROTAC design. ChemMedChem 18, e202200615. https:\/\/doi.org\/10.1002\/cmdc.202200615 (2023).","journal-title":"ChemMedChem"},{"key":"77460_CR43","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 https:\/\/doi.org\/10.1093\/nar\/gkae1011 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77460-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77460-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77460-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:39:56Z","timestamp":1789670396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77460-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77460"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77460-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9929"}}